Pulmonary Vascular Disease News

A novel blood test that measures elevated circulating cell-free DNA may be used to evaluate disease severity and predict worse survival in patients with pulmonary arterial hypertension, according to new data published in Circulation.

A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.

A new analysis in Respiratory Medicine found that about one in eight patients with acute pulmonary embolism also have atrial fibrillation, which was associated with increased short- and long-term mortality.

Selexipag improved pulmonary vascular resistance and other hemodynamic variables among patients with chronic thromboembolic pulmonary hypertension, according to results published in European Respiratory Journal.

The Healio Editors compiled the most-read news in pulmonology posted in July.

The Mayo Clinic in Rochester, Minnesota, was ranked No. 1 on U.S. News & World Report’s list of Best Hospitals for pulmonology and lung surgery.

An artificial intelligence tool for detecting incidental pulmonary embolus on conventional contrast-enhanced chest CT had high negative predictive value and moderate positive predictive value for detection, researchers reported.

Patients with normal renal function who have tested positive for COVID-19 and are undergoing chest CT angiography may not have an increased risk for contrast-associated AKI.

Interstitial lung disease and pulmonary arterial hypertension associated with scleroderma often require consultations and co-management with physicians outside of rheumatology.

SAN FRANCISCO — Inhaled treprostinil significantly improved persistence, adherence and lowered risk for hospitalization compared with iloprost in patients with pulmonary arterial hypertension, researchers reported.